After Leerink Partners and Oppenheimer gave Aldeyra Therapeutics (NASDAQ: ALDX) a Buy rating last month, the company received another Buy, this time from ...
The post Aldeyra Therapeutics (ALDX) Received its Third Buy in a Row appeared first on Smarter Analyst.
After Leerink Partners and Oppenheimer...

https://www.smarteranalyst.com/new-blurbs/aldeyra-therapeutics-aldx-received-its-third-buy-in-a-row-3/

#SmarterAnalyst